News
September 9, 2022
U.S.-based lawyers with extensive experience explain the latest litigation cases and trends for Japanese companies
March 15, 2023
U.S.-based lawyers with extensive experience explain the latest litigation cases and trends for Japanese companies
August 29, 2023
NEW YORK, August 29, 2023 – FRONTEO (TSE: 2158) announces today that the number of registered members of the FRONTEO Legal Link Portal (https://legal.fronteo.com/fllp/; hereinafter "FLLP"), one of the largest membership-based legal platforms in Japan, has reached 12,000.
February 7, 2022
Nishimura & Asahi and FRONTEO hold "Economic Security Initiative
January 16, 2023
NEW YORK, January 16, 2023 – FRONTEO (TSE: 2158) has announced today that its proprietary AI engine "KIBIT" has successfully improved Japanese language processing in natural language processing.
April 4, 2023
FRONTEO changes AI engine and product names to strengthen brand power and promote market penetration
January 16, 2025
FRONTEO’s Drug Discovery AI Factory, an AI drug discovery service using unique technologies that discover unreported relationships from published literature, to support target identification and drug repositioning etc.
January 30, 2024
We have enhanced our existing forensic services with new cutting-edge digital forensics software package, and we are working on adding more certified forensic experts to our staff.
August 4, 2021
NEW YORK, August 4, 2021 – FRONTEO (TSE: 2158) announced that our AI review tool "KIBIT Automator" was used for an investigative case of unauthorized access and removal of confidential information in the United States.
August 25, 2023
FRONTEO was thrilled to sponsor and attend ILTACON 2023, which was held this year in Orlando, FL, from August 20th through August 24th.
January 31, 2023
Reduced review time and costs for companies and attorneys involved in litigation
May 13, 2024
FRONTEO, Inc. (Head Office: Tokyo, Japan; Chief Executive Officer: Masahiro Morimoto; hereafter "FRONTEO"), Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi; hereafter "Shionogi"), and Suzuken Co., Ltd. (Head Office: Nagoya, Japan; President and CEO: Shigeru Asano; hereafter "Suzuken") are pleased to announce that we will collaborate with the aim of implementing the conversational dementia diagnosis support AI program in society.
January 24, 2024
Explanation of points to keep in mind when Japanese companies negotiate with U.S. government agencies, crisis management, and the use of AI